NASDAQ:NRC National Research (NRC) Stock Forecast, Price & News $44.61 -0.73 (-1.61%) (As of 01:47 PM ET) Add Compare Share Share Today's Range$44.61▼$45.6550-Day Range$41.80▼$46.7852-Week Range$34.69▼$47.60Volume7,406 shsAverage Volume35,849 shsMarket Capitalization$1.10 billionP/E Ratio38.13Dividend Yield1.08%Price TargetN/A ProfileProfileChartCompetitorsDividendEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesSEC FilingsShort InterestSocial MediaProfileChartCompetitorsDividendEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesSEC FilingsShort InterestSocial Media National Research MarketRank™ ForecastAnalyst RatingN/AUpside/DownsideN/AShort InterestBearish1.89% of Float Sold ShortDividend StrengthWeakBased on Four FactorsSustainabilityN/ANews Sentiment0.75Based on 6 Articles This WeekInsider TradingN/AProj. Earnings GrowthN/ASee Full Details Hide Full Details Overall MarketRank™MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.1.40 out of 5 starsBusiness Services Sector241st out of 317 stocksCommercial Physical Research Industry13th out of 14 stocks N/A Analyst's Opinion Consensus RatingThere is not enough analysis data for National Research. Previous Next 2.0 Short Interest Percentage of Shares Shorted1.89% of the float of National Research has been sold short.Short Interest Ratio / Days to CoverNational Research has a short interest ratio ("days to cover") of 9.7.Change versus previous monthShort interest in National Research has recently increased by 163.21%, indicating that investor sentiment is decreasing significantly. Previous Next 1.7 Dividend Strength Dividend YieldNational Research pays a meaningful dividend of 1.04%, higher than the bottom 25% of all stocks that pay dividends.Dividend GrowthNational Research does not have a long track record of dividend growth.Dividend CoverageThe dividend payout ratio of National Research is 41.03%. This payout ratio is at a healthy, sustainable level, below 75%. Previous Next N/A Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreThere is no current Upright™ data available for NRC. Previous Next 2.6 News and Social Media Coverage News SentimentNational Research has a news sentiment score of 0.75. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This news sentiment score is similar to the average news sentiment of Business Services companies.News Coverage This WeekMarketBeat has tracked 6 news articles for National Research this week, compared to 2 articles on an average week.Search Interest1 people have searched for NRC on MarketBeat in the last 30 days. Previous Next 0.8 Company Ownership Insider Buying vs. Insider SellingIn the past three months, National Research insiders have not sold or bought any company stock.Percentage Held by InsidersOnly 2.40% of the stock of National Research is held by insiders.Percentage Held by Institutions47.26% of the stock of National Research is held by institutions. High institutional ownership can be a signal of strong market trust in this company. Previous Next 0.6 Earnings and Valuation Price to Earnings Ratio vs. the MarketThe P/E ratio of National Research is 38.75, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 114.72.Price to Earnings Ratio vs. SectorThe P/E ratio of National Research is 38.75, which means that it is trading at a more expensive P/E ratio than the Business Services sector average P/E ratio of about 29.45.Price to Book Value per Share RatioNational Research has a P/B Ratio of 15.53. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities. Previous Next See Top Rated MarketRank™ Stocks Here About National Research (NASDAQ:NRC) StockNational Research Corporation provides analytics and insights that facilitate measurement and enhancement of the patient and employee experience in the United States and Canada. Its portfolio of subscription-based solutions provides actionable information and analysis to healthcare organizations across a range of mission-critical, constituent-related elements, including patient experience, service recovery, care transitions, health risk assessments, employee engagement, reputation management, and brand loyalty. The company also offers market insights solutions that allow the tracking of awareness, perception, and consistency of healthcare brands; assessment of competitive differentiators; and enhanced segmentation tools to evaluate needs, wants, and behaviors of communities through real-time competitive assessments and enhanced segmentation tools. In addition, it provides experience solutions, such as patient experience, workforce engagement, health risk assessments, care transition, and improvement tools. Further, the company provides reputation solutions that allow healthcare organizations to share a picture of their organization and ensure that timely and relevant content informs consumer decision-making; and governance solutions for not-for-profit hospital and health system boards of directors, executives, and physician leadership. National Research Corporation was founded in 1981 and is headquartered in Lincoln, Nebraska.Read More NRC Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart NRC Stock News HeadlinesSeptember 26, 2023 | finance.yahoo.comLurie Children’s expands partnership with NRC Health to gain valuable consumer insightsSeptember 21, 2023 | news.yahoo.comGovernment approves £105m Stanford Hall NHS rehabilitation centreSeptember 27, 2023 | Edge On The Street (Ad)Is Gold Really Boring?Many investors perceive gold as a "boring" investment. But according to MoneyWeek, that's a good thing. Gold helps investors sleep soundly as it preserves wealth and creates a hedge against inflation. Today, there's a unique way to invest in gold, with real advantages over coins and mining stocks. September 21, 2023 | msn.comGovernment approves £105m NHS rehabilitation centreSeptember 17, 2023 | americanbankingnews.comNational Research (NASDAQ:NRC) Shares Gap Down to $46.15September 15, 2023 | finance.yahoo.comUnveiling National Research Corp's Dividend Profile: A Comprehensive AnalysisSeptember 7, 2023 | finance.yahoo.comUnveiling National Research (NRC)'s Value: Is It Really Priced Right? A Comprehensive GuideSeptember 6, 2023 | finance.yahoo.comNational Research Corporation Declares Special DividendSeptember 27, 2023 | Wall Street Fundamentals (Ad)The "Plug and Play" Model Putting Online Giants to ShameWhile e-commerce has been undergoing a turbulent time, a "simple" model has grown 4X faster than Amazon over the last 3 years. Applying this model to high-margin, recession-resistant businesses has shown to be profitable. But that's just the beginning of explaining the 400+% growth - and potential - of this "diamond in the rough."August 31, 2023 | finance.yahoo.comNRC Health emphasizes its commitment to ICD’s annual Patient Experience SymposiumAugust 29, 2023 | finance.yahoo.comLifeBridge Health selects NRC Health as its new patient experience partnerAugust 29, 2023 | finance.yahoo.comLaurent Pharmaceuticals Receives Health Canada’s Approval to Initiate Phase 2/3 Clinical Trial in Long COVIDAugust 27, 2023 | finance.yahoo.comNational Research's (NASDAQ:NRC) investors will be pleased with their 28% return over the last yearAugust 15, 2023 | seekingalpha.comNational Research: Economics Well Priced In, Future Value May Be Crimped (Rating Downgrade)August 14, 2023 | msn.comPureHealth to integrate National Rehabiltation Center in Abu Dhabi into its networkAugust 8, 2023 | finance.yahoo.comNRC Health unveils winners of 2023 patient experience and loyalty awardsAugust 3, 2023 | powermag.comTwo Big Nuclear Regulatory Milestones for Idaho NuScale SMR ProjectAugust 1, 2023 | finance.yahoo.comNational Research Corporation Announces Second Quarter 2023 ResultsJuly 29, 2023 | finanznachrichten.deAcuva Technologies Inc.: Acuva Secures Funding for R&D Project Through Innovative Solutions CanadaJuly 28, 2023 | markets.businessinsider.comVogtle Unit 4 has received the 103(g) finding from the Nuclear Regulatory CommissionJuly 28, 2023 | finance.yahoo.comAcuva Secures Funding for R&D Project Through Innovative Solutions CanadaJuly 21, 2023 | msn.comAll ITAACs have been submitted for Plant Vogtle Unit 4July 18, 2023 | finance.yahoo.comNational Research Corporation to Broadcast its 2023 Second Quarter Conference Call Live on the InternetJuly 14, 2023 | fool.comNational Research (NASDAQ: NRC)July 12, 2023 | finance.yahoo.comBryan Health Chooses NRC Health as Patient Experience PartnerJuly 11, 2023 | finance.yahoo.comNext Hydrogen recipient of funding for technology developmentJuly 5, 2023 | msn.comWanted: A Clear-Cut Policy on ImmigrationSee More Headlines Receive NRC Stock News and Ratings via Email Sign-up to receive the latest news and ratings for National Research and its competitors with MarketBeat's FREE daily newsletter. Email Address NRC Company Calendar Last Earnings8/01/2023Ex-Dividend for 9/22 Dividend9/15/2023Dividend Payable9/22/2023Today9/27/2023Ex-Dividend for 10/13 Dividend9/28/2023Dividend Payable10/13/2023Next Earnings (Estimated)11/07/2023Fiscal Year End12/31/2023Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ Industry Commercial physical research Sub-IndustryN/A SectorBusiness Services Current SymbolNASDAQ:NRC CUSIPN/A CIK70487 Webwww.nrchealth.com Phone(402) 475-2525Fax402-475-9061Employees491Year Founded1981Profitability EPS (Most Recent Fiscal Year)$1.17 Trailing P/E Ratio38.14 Forward P/E RatioN/A P/E GrowthN/ANet Income$31.80 million Net Margins19.65% Pretax Margin26.11% Return on Equity39.94% Return on Assets21.88% Debt Debt-to-Equity Ratio0.20 Current Ratio1.21 Quick Ratio1.21 Sales & Book Value Annual Sales$151.57 million Price / Sales7.23 Cash Flow$1.46 per share Price / Cash Flow30.51 Book Value$2.92 per share Price / Book15.28Miscellaneous Outstanding Shares24,570,000Free Float23,978,000Market Cap$1.10 billion OptionableNot Optionable Beta0.48 Social Links The Best High-Yield Dividend Stocks for 2023Looking to generate income with your stock portfolio? Use these ten stocks to generate a safe and reliable source of investment income.Get This Free Report Key ExecutivesMr. Michael D. Hays (Age 68)Founder, CEO, Pres & Director Comp: $131.65kMr. Kevin R. Karas C.P.A. (Age 65)CPA, Sr. VP of Fin., CFO, Treasurer & Sec. Comp: $292.81kMs. Jona S. Raasch (Age 64)Chief Operating Officer Comp: $308.01kMs. Helen L. Hrdy (Age 58)Chief Growth Officer Comp: $291.31kMr. Jon BoumsteinChief Delivery OfficerDr. Gregory Makoul M.S.Ph.D., Chief Transformation OfficerLinda StacyVP of Fin.Megan CharkoSr. Mang. of Content MarketingMore ExecutivesKey CompetitorsSomaLogicNASDAQ:SLGCDada NexusNASDAQ:DADAEcovystNYSE:ECVTBrookfield Business PartnersNYSE:BBUAdeiaNASDAQ:ADEAView All CompetitorsInsiders & InstitutionsPortside Wealth Group LLCBought 4,862 shares on 9/1/2023Ownership: 0.020%California State Teachers Retirement SystemSold 471 shares on 8/21/2023Ownership: 0.072%Nuveen Asset Management LLCBought 616 shares on 8/16/2023Ownership: 0.233%Royal Bank of CanadaSold 268 shares on 8/15/2023Ownership: 0.131%Alliancebernstein L.P.Sold 300 shares on 8/15/2023Ownership: 0.060%View All Insider TransactionsView All Institutional Transactions NRC Stock - Frequently Asked Questions How have NRC shares performed in 2023? National Research's stock was trading at $37.30 at the beginning of 2023. Since then, NRC shares have increased by 19.6% and is now trading at $44.62. View the best growth stocks for 2023 here. Are investors shorting National Research? National Research saw a increase in short interest during the month of September. As of September 15th, there was short interest totaling 271,900 shares, an increase of 163.2% from the August 31st total of 103,300 shares. Based on an average daily volume of 27,900 shares, the short-interest ratio is currently 9.7 days. Currently, 1.9% of the shares of the company are short sold. View National Research's Short Interest. When is National Research's next earnings date? The company is scheduled to release its next quarterly earnings announcement on Tuesday, November 7th 2023. View our NRC earnings forecast. How were National Research's earnings last quarter? National Research Co. (NASDAQ:NRC) announced its quarterly earnings results on Tuesday, August, 1st. The company reported $0.29 EPS for the quarter. The firm had revenue of $36.16 million for the quarter. National Research had a net margin of 19.65% and a trailing twelve-month return on equity of 39.94%. How often does National Research pay dividends? What is the dividend yield for National Research? National Research announced a None dividend on Wednesday, September 6th. Investors of record on Monday, September 18th will be paid a dividend of $1.00 per share on Friday, September 22nd. The ex-dividend date is Friday, September 15th. Read our dividend analysis for NRC. What ETF holds National Research's stock ? Small Cap US Equity Select ETF holds 16,946 shares of NRC stock, representing 2.76% of its portfolio. Is National Research a good dividend stock? National Research (NASDAQ:NRC) pays an annual dividend of $0.48 per share and currently has a dividend yield of 1.04%. The dividend payout ratio is 41.03%. This payout ratio is at a healthy, sustainable level, below 75%. Read our dividend analysis for NRC. What is Michael D. Hays' approval rating as National Research's CEO? 85 employees have rated National Research Chief Executive Officer Michael D. Hays on Glassdoor.com. Michael D. Hays has an approval rating of 87% among the company's employees. What other stocks do shareholders of National Research own? Based on aggregate information from My MarketBeat watchlists, some companies that other National Research investors own include Altria Group (MO), Enterprise Products Partners (EPD), AbbVie (ABBV), Dominion Energy (D), Gilead Sciences (GILD), Pfizer (PFE), Toronto-Dominion Bank (TD), Verizon Communications (VZ), Wells Fargo & Company (WFC) and TD Ameritrade (AMTD). What is National Research's stock symbol? National Research trades on the NASDAQ under the ticker symbol "NRC." Who are National Research's major shareholders? National Research's stock is owned by many different institutional and retail investors. Top institutional shareholders include Kayne Anderson Rudnick Investment Management LLC (13.04%), BlackRock Inc. (4.38%), Conestoga Capital Advisors LLC (2.97%), QV Investors Inc. (1.83%), Renaissance Technologies LLC (1.50%) and State Street Corp (1.34%). Insiders that own company stock include Amandla Mk Trust, Joann M Martin, Jona S Raasch and Kevin R Karas. View institutional ownership trends. How do I buy shares of National Research? Shares of NRC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here. What is National Research's stock price today? One share of NRC stock can currently be purchased for approximately $44.62. How much money does National Research make? National Research (NASDAQ:NRC) has a market capitalization of $1.10 billion and generates $151.57 million in revenue each year. The company earns $31.80 million in net income (profit) each year or $1.17 on an earnings per share basis. How many employees does National Research have? The company employs 491 workers across the globe. Does National Research have any subsidiaries? The following companies are subsidiares of National Research: National Research Corporation Canada, PatientWisdom Inc., and The Governance Institute.Read More How can I contact National Research? National Research's mailing address is 1245 Q STREET, LINCOLN NE, 68508. The official website for the company is www.nrchealth.com. The company can be reached via phone at (402) 475-2525 or via fax at 402-475-9061. This page (NASDAQ:NRC) was last updated on 9/27/2023 by MarketBeat.com Staff Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding National Research Co. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.